Variability of the Field Potential Duration of Stem Cell-Derived Cardiomyocytes is a Proarrhythmic Indicator

被引:0
|
作者
Bruening-Wright, Andrew [1 ]
Obejero-Paz, Carlos A. [1 ]
Kramer, James [1 ]
Brown, Arthur M. [1 ]
机构
[1] ChanTest, Discovery Serv, Cleveland, OH USA
关键词
D O I
10.1016/j.bpj.2015.11.1473
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
1338-Pos
引用
收藏
页码:271A / 271A
页数:1
相关论文
共 50 条
  • [1] Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
    Jonsson, Malin K. B.
    Duker, Goran
    Tropp, Charlotte
    Andersson, Birgit
    Sartipy, Peter
    Vos, Marc A.
    van Veen, Toon A. B.
    STEM CELL RESEARCH, 2010, 4 (03) : 189 - 200
  • [2] Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Patel, Dakshesh
    Stohlman, Jayna
    Dang, Qianyu
    Strauss, David G.
    Blinova, Ksenia
    TOXICOLOGICAL SCIENCES, 2019, 170 (01) : 167 - 179
  • [3] Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets
    Izumi-Nakaseko, Hiroko
    Kanda, Yasunari
    Nakamura, Yuji
    Hagiwara-Nagasawa, Mihoko
    Wada, Takeshi
    Ando, Kentaro
    Naito, Atsuhiko T.
    Sekino, Yuko
    Sugiyama, Atsushi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 135 (01) : 44 - 50
  • [4] Stem cell-derived cardiomyocytes demonstrate arrhythmic potential
    Zhang, YM
    Hartzell, C
    Narlow, M
    Dudley, SC
    CIRCULATION, 2002, 106 (10) : 1294 - 1299
  • [5] International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
    Blinova, Ksenia
    Dang, Qianyu
    Millard, Daniel
    Smith, Godfrey
    Pierson, Jennifer
    Guo, Liang
    Brock, Mathew
    Lu, Hua Rong
    Kraushaar, Udo
    Zeng, Haoyu
    Shi, Hong
    Zhang, Xiaoyu
    Sawada, Kohei
    Osada, Tomoharu
    Kanda, Yasunari
    Sekino, Yuko
    Pang, Li
    Feaster, Tromondae K.
    Kettenhofen, Ralf
    Stockbridge, Norman
    Strauss, David G.
    Gintant, Gary
    CELL REPORTS, 2018, 24 (13): : 3582 - 3592
  • [6] Proarrhythmic risk evaluation of vanoxerine in normal and hypertrophic cardiomyopathy human stem cell-derived cardiomyocytes
    Shi, Hong
    Huang, Minxue
    Levesque, Paul
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 168 - 169
  • [7] Stem cell-derived cardiomyocytes demonstrate arrhythmic potential - Response
    Dudley, SC
    Narlow, M
    Zhang, YM
    Hartzell, C
    CIRCULATION, 2003, 107 (20) : E195 - E195
  • [8] Potential applications of human embryonic stem cell-derived cardiomyocytes
    Caspi, O
    Gepstein, L
    CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION, 2004, 1015 : 285 - 298
  • [9] Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Biendarra-Tiegs, Sherri M.
    Secreto, Frank J.
    Nelson, Timothy J.
    CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 6: STEM CELLS: THEIR HETEROGENEITY, NICHE AND REGENERATIVE POTENTIAL, 2020, 1212 : 1 - 29
  • [10] Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
    Carvalho, A. B.
    Coutinho, Keyla Cristiny da Silva
    Barbosa, Raiana Andrade Quintanilha
    Campos, Dilza Balteiro Pereira de
    Leitao, Isabela de Carvalho
    Pinto, R. S.
    Dos Santos, D. Silva
    Farjun, Bruna
    De Araujo, Dayana da Silva
    Mesquita, Fernanda Cristina Paccola
    Monnerat-Cahli, G.
    Medei, E. H.
    Kasai-Brunswick, Tais Hanae
    De Carvalho, A. C. Campos
    FRONTIERS IN PHYSIOLOGY, 2022, 13